| 今开：31.7 | 昨收：31.67 |
| 最高：32.01 | 最低：31.31 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.769575732E9 |
Agios(AGIO)02-13 19:15
$Agios制药(AGIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-032786 Act: 34 Size: 49 KB 网页链接查看全文
Agios(AGIO)02-13 00:25
$Agios制药(AGIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-013960 Act: 34 Size: 13 KB 网页链接查看全文
Agios(AGIO)02-28 06:05
$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001483 Act: 33 Size: 6 KB 网页链接查看全文
Agios(AGIO)03-06 05:25
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000052 Size: 13 KB 网页链接查看全文
Agios(AGIO)03-06 05:25
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000050 Size: 16 KB 网页链接查看全文
Agios(AGIO)今天 04:15
$Agios(AGIO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-117998 Act: 34 Size: 2 MB 网页链接查看全文
Agios(AGIO)03-08 07:55
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000058 Size: 7 KB 网页链接查看全文
Agios(AGIO)03-06 05:15
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000044 Size: 7 KB 网页链接查看全文
Agios(AGIO)03-02 05:25
$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001546216-24-000001 Act: 33 Size: 4 KB 网页链接查看全文
Agios(AGIO)03-02 05:45
$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001546216-24-000004 Act: 33 Size: 5 KB 网页链接查看全文
药明康德2019-01-28 19:41
▎医药观澜/报道
1月28日，基石药业（苏州）有限公司（下称基石药业）宣布，中国国家药品监督管理局（NMPA）近期批准公司成纤维细胞生长因子受体-4（FGFR4）抑制剂BLU-554（CS3008）在中国开展1期临床试验。BLU-554由公司合作伙伴Blueprint Medicines开发，基石药业拥有此款产品在大中华区的...查看全文
药明康德2018-11-02 10:33
▎医药观澜/报道
2018年11月1日，基石药业（苏州）有限公司（下称基石药业）宣布，随着10月首批患者顺利入组和给药，CS1001的中国3期临床试验GEMSTONE-301顺利启动。CS1001是基石药业自主研发的国内首个全人源、自然全长的PD-L1单抗。该试验针对中国同步/序贯放化疗后未发生疾病进展的局部晚...查看全文
用户18509225712018-10-19 08:59
$Agios Pharmaceuticals, Inc. (AGIO)$ Agios to Webcast Conference Call of Third Quarter 2018 Financial Results on November 1, 2018 Nasdaq:AGIO
网页链接查看全文
H3llinger2018-09-05 06:30
Time to buy $Agios Pharmaceuticals, Inc. (AGIO)$ for the sake of Dr. Fouse?查看全文
行舟Drug2018-07-02 00:02
点击上方的 行舟Drug ▲ 添加关注
看到这条新闻，我想起我们著名生物学家李教授，苦心钻研三十年，成功培育出抗寒蚊子，填补了冬天没有蚊子的空白 。小伙伴儿们来了解一下本周医药圈发生的新鲜事吧~
一周大事
1
诺华宣布剥离爱尔康
6月29日，诺华制药宣布拟剥离爱尔康...查看全文
新康界2018-06-30 11:21
会议报名点击阅读原文
文：新康界整理
转载请注明作者和来自新康界（XKJ0101)
本周（6月24-30日），政策方面，国家中医药管理局新党政班子“出炉”，余艳红任党组书记，于文明任局长；。企业方面，同济堂取消三亿元分红，继续保持不分红纪录；步长制药公布系列核心产品销售数据和利...查看全文
$Agios(AGIO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-117966 Act: 34 Size: 435 KB 网页链接
$Agios(AGIO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-117998 Act: 34 Size: 2 MB 网页链接
$Agios(AGIO)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-117951 Act: 34 Size: 4 MB 网页链接
$Agios(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000063 Size: 8 KB 网页链接
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000061 Size: 5 KB 网页链接
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000056 Size: 4 KB 网页链接
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000058 Size: 7 KB 网页链接
$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002026 Act: 33 Size: 6 KB 网页链接
$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001982 Act: 33 Size: 6 KB 网页链接
$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001926 Act: 33 Size: 5 KB 网页链接